Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes

Cardiovascular Research

Volumn 38, Issue 2, 1998, Pages 441-450

  Bosch, Ralph F ^a   Gaspo, Rania ^a   Busch, Andreas E ^d   Lang, Hans J ^e   Li, Gui Rong ^a,b   Nattel, Stanley ^a,b,c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e SANOFI   (France)

Author keywords

Action potential; Antiarrhythmic drugs; Biophysics; Cardiac arrhythmias; Potassium channels

Indexed keywords

ANTIARRHYTHMIC AGENT; CALCIUM ION; CHROMANOL 293 B; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; SODIUM ION; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CALCIUM CURRENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; GUINEA PIG; HEART MUSCLE CELL; HEART REPOLARIZATION; HEART VENTRICLE; HUMAN; HUMAN CELL; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; SODIUM CURRENT;

ACTION POTENTIALS; ANIMALS; CALCIUM CHANNELS; CHROMANS; GUINEA PIGS; HUMANS; MYOCARDIUM; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; SODIUM CHANNELS; SULFONAMIDES;

EID: 0032076162     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00021-2     Document Type: Article

References (53)

1. [1] The Cardiac Arrhythmia Suppression Trial (CAST) Investigators, Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New Engl J Med 1989;321:406-411. Preliminary report.
2. [2] The Cardiac Arrhythmia Suppression Trial II Investigators, Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. New Engl J Med 1992;327:227-233.
3. [3] Singh BN, Vaughan Williams EM. A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmocological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol 1970;39:675-687.
4. [4] Singh BN, Vaughan Williams EM. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol 1970;39:657-667.
5. + current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990;96:195-215.
6. + current by dofetilide. Circ Res 1993;72:75-83.
7. [7] Argentieri TM, Carroll MS, Sullivan ME. Cellular electrophysiological effects of the class III antiarrhythmic agents sematilide and clofilium on rabbit atrial tissues. J Cardiovasc Pharmacol 1991;18:167-174.
8. [8] Nattel S, Zeng FD. Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers. J Pharmacol Exp Ther 1984;229:283-291.
9. [9] Carlsson L, Almgren O, Duker G. QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit. Etiology and interventions. J Cardiovasc Pharmacol 1990;16:276-285.
10. + conductance. Pflüg Arch -Eur J Physiol 1995;429:517-530.
11. sK channels by the chromanol 293B. Pflüg Arch - Eur J Physiol 1996;432:1094-1096.
12. [12] Näbauer M, Beuckelmann DJ, Erdmann E. Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res 1993;73:386-394.
13. + current in human ventricular myocytes. Circ Res 1996;78:689-696.
14. [14] Mason JW, Hondeghem LM, Katzung BG. Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res 1984;55:277-285.
15. [15] Nattel S, Talajic M, Quantz M, DeRoode M. Frequency-dependent effects of amiodarone on atrioventricular nodal function and slow-channel action potentials. Evidence for calcium-channel blocking activity. Circulation 1987;76:442-449.
16. [16] Nishimura M, Follmer CH, Singer DH. Amiodarone blocks calcium current in single guinea pig ventricular myocytes. J Pharmacol Exp Ther 1989;251:650-659.
17. [17] Charlier R. Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors. Br J Pharmacol 1970;39:668-674.
18. [18] Sato R, Koumi SI, Singer DH, et al. Amiodarone blocks the inward rectifier potassium channel in isolated guinea pig ventricular cells. J Pharmacol Exp Ther 1994;269:1213-1219.
19. [19] Bosch RF, Li GR, Gaspo R, Nattel S. Ionic mechanisms of electrophysiologic effects of chronic amiodarone therapy and hypothyroidism - Does amiodarone act via cardiac hypothyroidism. Circulation 1996;94:I-161. (Abstract) Suppl. I.
20. [20] Varró A, Virág L, Papp JG. Comparison of the chronic and acute effects of amiodarone on the calcium and potassium currents in rabbit isolated cardiac myocytes. Br J Pharmacol 1996;117:1181-1186.
21. [21] Balser JR, Bennett PB, Hondeghem LM, Roden DM. Suppression of time-dependent outward current in guinea pig ventricular myocytes. Actions of quinidine and amiodarone. Circ Res 1991;69:519-529.
22. + current in guinea pig ventricular cells. J Pharmacol Exp Ther 1992;262:99-108.
23. Kr) in AT-1 cells. Circulation 1995;91:1799-1806.
24. [24] Chinn K. Two delayed rectifiers in guinea pig ventricular myocytes distinguished by tail current kinetics. J Pharmacol Exp Ther 1993;264:553-560.
25. [25] Kiehn J, Villena P, Beyer T, Brachmann J. Differential effects of the new class III agent dofetilide on potassium currents in guinea pig cardiomyocytes. J Cardiovasc Pharmacol 1994;24:566-572.
26. [26] Wang J, Bourne GW, Wang Z, Villemaire C, Talajic M. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation: Importance of use-dependent effects on refractoriness. Circulation 1993;88:1030-1044.
27. [27] Wang J, Feng J, Nattel S. Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide. Circulation 1994;90:2032-2040.
28. [28] Roden DM. Current status of class III antiarrhythmic drug therapy. Am J Cardiol 1993;72:44B-49B.
29. K blocking drug, UK-68,798: Potent in guinea pig but no effect in rat myocardium. J Cardiovasc Pharmacol 1990;16:401-410.
30. max. Br J Pharmacol 1991;103:1568-1572.
31. [31] Todt H, Zojer N, Schütz W. Differential effect of dofetilide on ventricular repolarization during steady state and during restitution in vivo. J Cardiovasc Pharmacol 1994;24:1010-1013.
32. [32] Démolis JL, Funck-Brentano C, Ropers J, Ghadanfar M, Nichols DJ, Jaillon P. Influence of dofetilide on QT-interval duration and dispersion at various heart rates during exercise in humans. Circulation 1996;94:1592-1599.
33. [33] Hafner D, Berger F, Borchard U, Kullmann A, Scherlitz A. Electrophysiological characterization of the class III activity of sotalol and its enatiomers. New interpretation of use-dependent effects. Arzneim-Forsch Drug Res 1988;38:231-236.
34. [34] Gwilt M, Dalrymple HW, Burges RA, et al. Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agent. J Cardiovasc Pharmacol 1991;17:376-385.
35. [35] Varró A, Nakaya Y, Elharrar V, Surawicz B. Effect of antiarrhythmic drugs on the cycle length-dependent action potential duration in dog Purkinje and ventricular muscle fibers. J Cardiovasc Pharmacol 1986;8:178-185.
36. [36] Schmitt C, Brachmann J, Karch M, et al. Reverse use-dependent effects of sotalol demonstrated by recording monophasic action potentials of the right ventricle. Am J Cardiol 1991;68:1183-1187.
37. [37] Funck-Brentano C, Kibleur Y, Le Coz F, Poirier JM, Mallet A, Jaillon P. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans. Circulation 1991;83:536-545.
38. [38] Sager PT, Follmer C, Uppal P, Pruitt C, Godfrey R. The effects of β-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans. Circulation 1994;90:1811-1819.
39. [39] Zhang ZH, Follmer CH, Sarma JSM, Chen F, Singh BN. Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes. Block of delayed outward potassium current. J Pharmacol Exp Ther 1992;263:40-48.
40. [40] Koidl B, Flaschberger P, Schaffer P, et al. Effects of the class III antiarrhythmic drug ambasilide on outward currents in human atrial myocytes. Naunyn-Schmiedeberg's Arch Pharmacol 1996;353:226-232.
41. [41] Feng J, Wang Z, Li GR, Nattel S. Effects of class III drugs on transient outward and ultra-rapid delayed rectifier currents in human atrial myocytes. J Pharmacol Exp Ther 1997;281:384-392.
42. [42] Sanguinetti MC, Jurkiewicz NK, Scott A, Siegl PKS. Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action. Circ Res 1991;68:77-84.
43. + current. Circ Res 1997. In revision.
44. + current in ventricular myocytes of the guinea pig type. Theoretical formulation and their role in repolarization. Circ Res 1995;77:140-152.
45. [45] Wang Z, Fermini B, Nattel S. Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc Res 1994;28:1540-1546.
46. [46] Antzelevitch C, Sicouri S, Lukas A, Nesterenko VV, Liu DW, Di Diego JM. Regional differences in the electrophysiology of ventricular cells. Physiological and clinical implications. In: Zipes DP, Jalife J, editors. Cardiac Electrophysiology. From Cell to Bedside. Philadelphia: WB Saunders, 1995:228-245.
47. [47] Litovsky SH, Antzelevitch C. Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ Res 1988;62:116-126.
48. [48] Näbauer M, Beuckelmann DJ, Überfuhr P, Steinbeck G. Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation 1996;93:168-177.
49. [49] Drouin E, Charpentier F, Gauthier C, Laurent K, Le Marec H. Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells. J Am Coll Cardiol 1995;26:185-192.
50. [50] Li GR, Feng J, Carrier M, Nattel S. Transmural electrophysiological heterogeneity in the human ventricle. Circulation 1995;92:I-158. (Abstract) Suppl. I.
51. Ks contributes to the longer action potential of the M cell. Circ Res 1995;76:351-365.
52. Ks in electrical heterogeneity. Am J Physiol 1995;268:H604-H613.
53. [53] Antzelevitch C, Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves triggered activity and torsade de pointes. J Am Coll Cardiol 1994;23:259-277.